Medline Inc. Class A Common Stock Cash Flow Reinvestment Rate
Medline Inc. Class A Common Stock cash flow reinvestment rate. Medline Inc. Class A Common Stock (MDLN) has a Cash Flow Reinvestment Rate of 0.16x as of June 2026, reinvesting $111.00 Million (capex $111.00 Million ) from operating cash flow of $715.00 Million. Explore debt repayment capacity of Medline Inc. Class A Common Stock to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Medline Inc. Class A Common Stock (2022–2025)
Cash flow reinvestment rate of Medline Inc. Class A Common Stock from 2022 to 2025. Historical reinvestment intensity for Medline Inc. Class A Common Stock across 4 annual periods. Explore Medline Inc. Class A Common Stock (MDLN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Medline Inc. Class A Common Stock Cash Flow Reinvestment Rate by Year (2022–2025)
Medline Inc. Class A Common Stock cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for Medline Inc. Class A Common Stock. For the full cash flow conversion analysis, see Medline Inc. Class A Common Stock (MDLN) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | $447.00 Million | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $364.00 Million | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $285.00 Million | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $254.00 Million | $187.00 Million | $254.00 Million | — |